APA (7th ed.) Citation

Modest, D., & Hofheinz, R. (2026). Integration of retifanlimab into the standard of care first-line therapy of advanced squamous anal cancer—lessons learned and open questions. Annals of Oncology, 37(8), 1028. https://doi.org/10.1016/j.annonc.2026.05.706

Chicago Style (17th ed.) Citation

Modest, D.P, and R.-D Hofheinz. "Integration of Retifanlimab into the Standard of Care First-line Therapy of Advanced Squamous Anal Cancer—lessons Learned and Open Questions." Annals of Oncology 37, no. 8 (2026): 1028. https://doi.org/10.1016/j.annonc.2026.05.706.

MLA (9th ed.) Citation

Modest, D.P, and R.-D Hofheinz. "Integration of Retifanlimab into the Standard of Care First-line Therapy of Advanced Squamous Anal Cancer—lessons Learned and Open Questions." Annals of Oncology, vol. 37, no. 8, 2026, p. 1028, https://doi.org/10.1016/j.annonc.2026.05.706.